These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6065987)
1. Detection of carriers of benign X-linked muscular dystrophy. Emery AE; Clack ER; Simon S; Taylor JL Br Med J; 1967 Dec; 4(5578):522-3. PubMed ID: 6065987 [No Abstract] [Full Text] [Related]
2. The detection of female carriers of pseudohypertrophic muscular dystrophy. Kakulas BA; Knight JO; Gubbay SS; Mastaglia FL Proc Aust Assoc Neurol; 1968; 5(3):545-51. PubMed ID: 5709982 [No Abstract] [Full Text] [Related]
3. X-linked muscular dystrophy, benign form with contractures. McKusick VA Birth Defects Orig Artic Ser; 1971 Feb; 7(2):113-5. PubMed ID: 5173119 [No Abstract] [Full Text] [Related]
4. Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers. Dennis NR; Evans K; Clayton B; Carter CO Br Med J; 1976 Sep; 2(6035):577-9. PubMed ID: 963439 [TBL] [Abstract][Full Text] [Related]
5. The detection of carriers of benign (Becker-type) X-linked muscular dystrophy. Skinner R; Emery AE; Anderson AJ; Foxall C J Med Genet; 1975 Jun; 12(2):131-4. PubMed ID: 1142377 [No Abstract] [Full Text] [Related]
6. Linkage between the loci for benign (Becker-type) X-borne muscular dystrophy and deutan colour blindness. Skinner R; Smith C; Emery AE J Med Genet; 1974 Dec; 11(4):317-20. PubMed ID: 4548442 [TBL] [Abstract][Full Text] [Related]
7. [An unusual form of benign hereditary recessive x-chromosomal muscular dystrophy]. Rotthauwe HW; Beyer H Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):410. PubMed ID: 5523692 [No Abstract] [Full Text] [Related]
8. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy. Perry TB; Fraser FC Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611 [No Abstract] [Full Text] [Related]
9. The detection of carriers of X-linked muscular dystrophy genes. A review of some methods studied in Newcastle upon Tyne. Gardner-Medwin D; Pennington RJ; Walton JN J Neurol Sci; 1971 Aug; 13(4):459-74. PubMed ID: 5570764 [No Abstract] [Full Text] [Related]
10. Pregnancy and serum C.P.K. levels in potential carriers of severe X-linked muscular dystrophy. Blyth H; Hughes BP Lancet; 1971 Apr; 1(7704):855-6. PubMed ID: 4102542 [No Abstract] [Full Text] [Related]
11. The neurogenic and myogenic hypotheses in human (Duchenne) muscular dystrophy. Thomson WH; Sweetin JC; Elton RA Nature; 1974 May; 249(453):151-2. PubMed ID: 4833513 [No Abstract] [Full Text] [Related]
14. The value of determination of serum creatine phosphokinase activity in detection of carriers of progressive muscular dystrophy. Hetnarska L Pol Med J; 1968; 7(1):224-7. PubMed ID: 5650194 [No Abstract] [Full Text] [Related]
15. [A benign X-chromosomal hereditary muscular dystrophy. I. Examinations of symptom-carriers]. Rotthauwe HW; Kowalewski S Humangenetik; 1966; 3(1):17-29. PubMed ID: 5986051 [No Abstract] [Full Text] [Related]
16. Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland. McCormick D; Allen IV Ulster Med J; 1976; 45(1):79-83. PubMed ID: 936362 [No Abstract] [Full Text] [Related]
17. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers]. László A; Salgó L Orv Hetil; 1981 Jun; 122(24):1453-6. PubMed ID: 7290660 [No Abstract] [Full Text] [Related]
18. Dilution effect on serum creatine kinase in carriers of Duchenne muscular dystrophy. Simpson AC; Holmes D; Pennington RJ Ann Clin Biochem; 1979 Jan; 16(1):54-5. PubMed ID: 420506 [No Abstract] [Full Text] [Related]